Volume Spike Investor

Boston Scientific Corporation (NYSE: BSX) is trading higher after last night’s announcement that it will immediately resume distribution of COGNIS(R) CRT-Ds and TELIGEN(R) ICDs in the U.S. BSX closed last night at $7.14 and the after-hours session saw a gain of 6.4% all the way up to $7.60 on a whopping 8,484,967 after-hours share volume. [...]

ICAgen Inc. (NASDAQ: ICGN) is soaring.  Shares closed at $0.54 on Monday and at 8:45 AM EST we have shares up 70% at $0.92 on about 85,000 shares.  Be advised that this micro-cap biotech was at $1.00 earlier this morning and that the 52-week trading range was $0.31 to $1.59.  The company reported positive results [...]

Is it ironic that Boston Scientific Corporation (NYSE: BSX) has another round of awful news out on one of its key products on the Ides of March? It gets harder and harder to imagine that this company is ever going to be able to manage a proper turnaround. The troubled medical device maker announced today [...]

We have provided a list of top day trader and active trader alert stocks this morning with a brief explanation of each move as well as what the move and trading volume is.  Time stamps are at approximately 8:45 AM EST. Activision Blizzard, Inc. (NASDAQ: ATVI) is trading up about 6% at $10.72 on almost [...]

J&J (JNJ) is up a tick to $61.16 and should open higher on news that it had prevailed in a patent dispute with Boston Scientific (BSX). The value of the settlement involving 16 stent patents is $716 million Douglas A. McIntyre

Boston Scientific (NYSE: BSX) is up nearly 6 percent to $10.90 in early premarket volume of about 1,100 shares. The company reported EPS of 20 cents a share excluding items, which still appears to be above analyst expectations of 13 cents a share. Revenue was nearly $2.1 billion, slightly above analyst expectations. — Mike Tarsala

Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI) has just exploded in trading volume and popped in price.  Shares as of 12:55 PM EST have seen 1.065 million shares trade hands, and the gain in 17% at $1.68.  Angiotech’s 52-week range is $0.10 to $3.00 and it trades an average of 2.5 million shares per day. NEWS:  While [...]

Boston Scientific (NYSE: BSX) shares are up 7% in strong premarket trading after the company and The University of Rochester Medical Center announced that the landmark MADIT-CRT trial has met its primary endpoint. The preliminary results showed the cardiac resynchronization therapy defibrillators with a significant 29% reduction in death or heart failure interventions when compared to [...]